To anyone who thinks the safety profile of these therapies has been determined, please keep this in mind. These are only two in a long list of potential unknown risks.
https://www.fda.gov/media/151733/download
"POSTMARKETING REQUIREMENTS UNDER SECTION 505(o)
1. Study C4591009, entitled “A Non-Interventional Post-Approval Safety Study of the Pfizer-BioNTech COVID-19 mRNA Vaccine in the United States,” to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY
Final Protocol Submission: August 31, 2021
Monitoring Report Submission: October 31, 2022
Interim Report Submission: October 31, 2023
Study Completion: June 30, 2025
Final Report Submission: October 31, 2025"
"POSTMARKETING COMMITMENTS SUBJECT TO REPORTING REQUIREMENTS UNDER SECTION 506B 7.
Study C4591022, entitled “Pfizer-BioNTech COVID-19 Vaccine Exposure during Pregnancy:
A Non-Interventional Post-Approval Safety Study of Pregnancy and Infant Outcomes in the Organization of Teratology Information Specialists (OTIS)/MotherToBaby Pregnancy Registry”
Final Protocol Submission: July 1, 2021
Study Completion: June 1, 2025
Final Report Submission: December 1, 2025"
- Forums
- Political Debate
- Pfizer risk for Myocarditis to be assessed by Oct 2025, risk to infants of pregnant vaccinated by Dec 2025
To anyone who thinks the safety profile of these therapies has...
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)